Results of a randomized trial with or without 5-FU-based preoperative chemotherapy followed by postoperative chemotherapy in resected colon and rectal carcinoma

Japanese Journal of Clinical Oncology

Volumn 33, Issue 6, 2003, Pages 288-296

  Kameoka, Shingo ^a   Tsuchiya, Shuji ^b   Hamano, Kyoichi ^a   Yasutomi, Masayuki ^c   Sakabe, Takashi ^d   Koyoma, Yasuo ^e   Takahashi, Takashi ^f   Kodaira, Susumu ^g   Muto, Tetsuichiro ^h   Kato, Tomoyuki ⁱ   Tominaga, Ken ^j   Ogawa, Nobuya ^k   Akimoto, Shin ^l   Uematsu, Toshihiko ^m   Fujii, Masashi ⁿ  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c KINKI UNIVERSITY   (Japan)

^d Konan University   (Japan)

^e TOCHIGI CANCER CENTER   (Japan)

^f CHIBA INSTITUTE OF SCIENCE   (Japan)

^g TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h CANCER INSTITUTE   (Japan)

ⁱ AICHI CANCER CENTER HOSPITAL   (Japan)

^j SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k EHIME UNIVERSITY   (Japan)

^l Yokohama General Hospital   (Japan)

^m GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁿ NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

5 fluorouracil; Colorectal cancer; Postoperative chemotherapy; Preoperative chemotherapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FLUOROURACIL; HEMOGLOBIN; MITOMYCIN C; ANTINEOPLASTIC AGENT; MITOMYCIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ANOREXIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; COLORECTAL CARCINOMA; COLORECTAL SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PATIENT COMPLIANCE; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; STOMATITIS; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL; COLON TUMOR; DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE PERIOD; RECTUM TUMOR; SURVIVAL RATE;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MITOMYCIN; POSTOPERATIVE PERIOD; RECTAL NEOPLASMS; SURVIVAL RATE;

EID: 0041783810     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyg049     Document Type: Article

References (18)

1. Kato T, Hirai T. Adjuvant chemotherapy and chemoradiation therapy for colorectal cancer. J Jpn Soc Coloproctol 2000;53:1000-7 (in Japanese).
2. The Colorectal Cancer Chemotherapy Study Group of Japan. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. Jpn J Clin Oncol 1995;25:91-103.
3. Takahashi T, Kato T, Kodaira S, Koyama Y, Sakabe T, Tominaga T, et al. Prognostic factors of colorectal cancer. Results of multivariate analysis of curative resection cases with or without adjuvant chemotherapy. Am J Clin Oncol 1996;19:408-15.
4. Tominaga T, Sakabe T, Koyama Y, Hamano K, Yasutomi M, Takahashi T, et al. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report. Cancer 1996;78:403-8.
5. Frei E III. What's in a name - neoadjuvant. J Natl Cancer Inst 1988;80: 1088-9 (Editorial).
6. Hong WK, Lippman SM, Wolf GT. Recent advances in head and neck cancer - larynx preservation and cancer chemoprevention. Cancer Res 1993;53:5113-20.
7. Bramwell VH, Burgers M, Sneath R, Souhami R, van Oosterom AT, Voute PA, et al. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma intergroup. J Clin Oncol 1992;10: 1579-91.
8. Lokich J, Bothe A, Fine N, Perri J. Phase I study of protracted venous infusion of 5-fluorouracil. Cancer 1981;48:2565-8.
9. Japanese Society for Cancer of the Colon and Rectum. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus, 4th ed. Tokyo: Kanehara 1986.
10. Japan Society for Cancer Therapy. Japanese criteria for the evaluation of the direct effects of cancer chemotherapy. J Jpn Soc Cancer Ther 1986;21: 931-42.
11. Japan Society for Cancer Therapy. Toxicity grading criteria of the Japan Society for Cancer Therapy. J Jpn Soc Cancer Ther 1997;32:61-5.
12. Gehan EA, Schneiderman MA. Experimental design of clinical trials. In: Holland JF, Frei E III, editors. Cancer Medicine. Philadelphia: Lea & Feibiger 1973.
13. Peti R, Peto J. Asymptomatically efficient rank invariant test procedures. J Am Stat Assoc 1985;53:457-81.
14. Katsumata K, Koyama Y, Tajima Y, Ishikawa H, Kanazawa K, Miyata M, et al. Evaluation of the usefulness of preoperative chemotherapy in patients with colorectal cancer; a multicenter cooperative study. Presented at the Japan Society for Cancer Therapy meeting, Sendai, October 22-24, 2000 (in Japanese).
15. Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, et al. Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidlate synthase and thymidine phosphorylase. Clin Cancer Res 2000;6:1322-7.
16. Fujii M, Kochi M, Kasakura Y, Mochizuki F, Kanamori N, Takahashi T, et al. Randomized trial of adjuvant chemotherapy by the result of histopathological evaluation of patients with operable colorectal cancer following preoperative chemotherapy using UFT. Presented at the American Society of Clinical Oncology Gastrointestinal Cancer meeting, New Orleans, LA, May 20-23, 2000.
17. Nakajima T, Ota K, Ishihara S, Oyama S, Nishi M, Ohashi Y, et al. Combined intensive chemotherapy and radical surgery for incurable gastric cancer. Ann Surg Oncol 1997;4:203-8.
18. Kotake K, Koyama Y, Hamano K, Yasutomi M, Kodaira S, Kato T, et al. Adjuvant chemotherapy in progressive colorectal cancer: A randomized comparative study of additional therapy with 5-FU CIV. Report No. 1. Presented at the Japan Society for Cancer Therapy meeting, Gifu, October 12-14, 1999 (in Japanese).